HI HCR35

Requests the State Auditor to assess the social and financial effects of requiring health insurers to cover medically necessary biomarker testing for diagnosis, treatment, management, and monitoring of diseases.

Biomarker testing analyzes tissue, blood, or other biospecimens for genes, proteins, and substances that provide information about a patient's condition, enabling personalized and targeted medical treatments.

The assessment relates to House Bill No. 1971 (2026), which would mandate coverage by insurers, mutual benefit societies, health maintenance organizations, and Medicaid managed care plans.

The Auditor must submit findings and recommendations to the Legislature no later than twenty days prior to the Regular Session of 2027.

Fulfills the requirement under Hawaii Revised Statutes sections 23-51 and 23-52 that proposed health insurance mandates undergo social and financial impact assessment before legislative consideration.